FDA approves combination therapy for chronic hepatitis C infection

被引：0
|
作者：
不详
机构：
来源：
LABORATORY MEDICINE | 2001年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：480 / 481
页数：2
相关论文
共 50 条
  • [31] Antiviral therapy for chronic hepatitis C viral infection
    Sherlock, S
    JOURNAL OF HEPATOLOGY, 1995, 23 : 3 - 7
  • [32] Shortening the duration of therapy for chronic hepatitis C infection
    Emmanuel, Benjamin
    Wilson, Eleanor M.
    O'Brien, Thomas R.
    Kottilil, Shyam
    Lau, George
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (11): : 832 - 836
  • [33] FDA APPROVES HEPATITIS-B VACCINE
    MAUGH, TH
    SCIENCE, 1981, 214 (4525) : 1113 - 1113
  • [34] FDA approves prevacid combination ulcer treatment
    不详
    AGRO FOOD INDUSTRY HI-TECH, 2003, 14 (06): : 53 - 53
  • [35] Leucopenia is a side effect of combination therapy for hepatitis C infection
    Russo, F
    Bacosi, M
    Miglioresi, L
    Ricci, GL
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (04): : 1100 - 1101
  • [36] The role of ribavirin in the combination therapy of hepatitis C virus infection
    Picardi, A
    Gentilucci, UV
    Zardi, EM
    D'Avola, D
    Amoroso, A
    Afeltra, A
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (17) : 2081 - 2092
  • [37] FDA approves SMA gene therapy
    Asher Mullard
    Nature Reviews Drug Discovery, 2019, 18 (7) : 488 - 488
  • [38] FDA approves ultrasound fibroid therapy
    Ringold, S
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (23): : 2826 - 2826
  • [39] FDA APPROVES DEVICE FOR THERAPY OF ADHD
    Passi, Gouri Rao
    INDIAN PEDIATRICS, 2019, 56 (06) : 517 - 517
  • [40] Filgrastim for the neutropenia associated with combination therapy in chronic hepatitis C
    Farmer, D
    Collantes, R
    Makay, S
    Ong, JP
    Gujral, H
    Farquhar, L
    Carniello, ML
    Sjogren, R
    Younossi, Z
    GASTROENTEROLOGY, 2005, 128 (04) : A725 - A725
12345